Your browser doesn't support javascript.
loading
The cardioprotective effect of the sodium-glucose cotransporter 2 inhibitor dapagliflozin in rats with isoproterenol-induced cardiomyopathy.
Wang, Fang-Zheng; Wei, Wen-Bo; Li, Xin; Huo, Jun-Yu; Jiang, Wan-Ying; Wang, Hong-Yu; Qian, Pei; Li, Zhen-Zhen; Zhou, Ye-Bo.
Afiliação
  • Wang FZ; Department of Physiology, Nanjing Medical University Nanjing 211166, Jiangsu, China.
  • Wei WB; Department of Cardiology, Nanjing BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University Nanjing 210021, Jiangsu, China.
  • Li X; Department of Cardiology, Nanjing BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University Nanjing 210021, Jiangsu, China.
  • Huo JY; Department of Cardiology, First Affiliated Hospital of Nanjing Medical University Nanjing 210006, Jiangsu, China.
  • Jiang WY; Department of Cardiology, First Affiliated Hospital of Nanjing Medical University Nanjing 210006, Jiangsu, China.
  • Wang HY; Department of Physiology, Nanjing Medical University Nanjing 211166, Jiangsu, China.
  • Qian P; Department of Physiology, Nanjing Medical University Nanjing 211166, Jiangsu, China.
  • Li ZZ; Department of Cardiology, Nanjing BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University Nanjing 210021, Jiangsu, China.
  • Zhou YB; Department of Physiology, Nanjing Medical University Nanjing 211166, Jiangsu, China.
Am J Transl Res ; 13(9): 10950-10961, 2021.
Article em En | MEDLINE | ID: mdl-34650776

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2021 Tipo de documento: Article